secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001386570-26-000017
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Niagen Bioscience increases share repurchase authorization to $20M from $10M
----------------------------------------------------------------------------

- Board approved increase of share repurchase program from $10M to $20M.
- Approximately $2.6M of common stock repurchased through March 17, 2026.
- Program runs through October 31, 2027, unless modified or terminated.
- CEO Rob Fried cited conviction in strategy and long-term value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000138657026000017/0001386570-26-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000138657026000017/cdxc-20260319.htm
  HTML page:      https://secwatch.observer/filing/0001386570-26-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer